Pediatric Psoriasis
Authors:
- 24 May 2017
- journal article
- review article
- Published by Springer Nature in American Journal of Clinical Dermatology
- Vol. 18 (6) , 797-811
Abstract
Psoriasis is a chronic inflammatory systemic disease associated with an important physical and physiological burden. It primarily affects the skin, but it is associated with several serious medical co-morbidities. One third of total psoriatic cases have their onset during the pediatric age, although some of them may not be diagnosed until the patient reaches adulthood. Additionally, in the pediatric age, there is an association with several medical co-morbidities; thus, an early recognition of the disease and a subsequent appropriate approach may delay or even prevent considerable co-morbidities. Because children are not just ‘small adults’, specific guidelines for the diagnosis, management, and treatment of psoriasis are of extreme importance. However, these guidelines are still lacking in this age group. Most of the psoriasis treatments used in adults are not officially approved for the pediatric age and require off-label prescription. Moreover, efficacy and safety studies are lacking in this population, especially with long-term follow-up and outcomes. Many biologic agents have been recently approved for the treatment of psoriasis in children, while others are currently being studied. This bibliographic review aims to summarize the most relevant aspects, as well as updated information about the epidemiology, pathogenesis, clinical features, diagnosis, co-morbidities and treatment of pediatric psoriasis.Keywords
This publication has 127 references indexed in Scilit:
- Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial through up to 3 yearsBritish Journal of Dermatology, 2012
- The Association of Psoriasis and Elevated Blood Lipids in Overweight and Obese ChildrenThe Journal of Pediatrics, 2011
- Prevalence of the Metabolic Syndrome in PsoriasisArchives of Dermatology, 2011
- Psoriasis genetics: breaking the barrierTrends in Genetics, 2010
- IL-22–producing “T22” T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17–producing TH17 T cellsJournal of Allergy and Clinical Immunology, 2009
- Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: A population‐based studyArthritis Care & Research, 2009
- Innate immunity and antimicrobial defense systems in psoriasisClinics in Dermatology, 2007
- Sequence and Haplotype Analysis Supports HLA-C as the Psoriasis Susceptibility 1 GeneThe American Journal of Human Genetics, 2006
- Pancytopenia induced by the interaction between methotrexate and trimethoprim-sulfamethoxazoleJournal of the American Academy of Dermatology, 1987
- Psoriasis of early and late onset: Characterization of two types of psoriasis vulgarisJournal of the American Academy of Dermatology, 1985